Status:
UNKNOWN
Circulatory Changes During Venovenous (VV)- and Venoarterial (VA) Extracorporeal Membrane Oxygenation (ECMO)
Lead Sponsor:
Radboud University Medical Center
Conditions:
Pulmonary Hypertension of the Newborn (PPHN)
Eligibility:
All Genders
Brief Summary
Rationale: Persistent pulmonary hypertension of the newborn (PPHN) is a life threatening disease with a high mortality rate. Extracorporeal Membrane Oxygenation (ECMO) with veno-arterial (V-A) or veno...
Eligibility Criteria
Inclusion
- Reversible cause of PPHN
- Newborn infant
- Older 34 weeks gestational age
Exclusion
- Congenital diaphragmatic hernia
- Congenital malformation
- Post-cardiosurgery
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00622492
Start Date
January 1 2008
End Date
October 1 2010
Last Update
February 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands, 6500 HB